GlassScriptPhysician profile
Anna Wilson Bunker
NPI 1376961565
$3,243.28
in general payments reported to CMS, 2019-2025
30 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.37 · 2020: $149 · 2021: $144 · 2022: $115 · 2023: $203 · 2024: $2,176 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,401 · Travel and Lodging: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,400.59 |
| Travel and Lodging | $397.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $943.26 | 2024 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $640.35 | 2024-2025 | Valtoco |
| Ucb, INC. | $362.80 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Jazz Pharmaceuticals INC. | $246.64 | 2022-2025 | |
| Abbvie INC. | $125.24 | 2022-2024 | Botox |
| Acadia Pharmaceuticals INC | $110.04 | 2023-2025 | Daybue |
| Ipsen Biopharmaceuticals, INC | $95.38 | 2023-2025 | Dysport |
| Immedica Pharma US, INC. | $94.95 | 2023-2024 | |
| Ironshore Pharmaceuticals INC. | $71.12 | 2023-2024 | Jornay Pm |
| Biocodex, INC. | $69.14 | 2024 | |
| Baxter Healthcare | $65.32 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $51.46 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $51.10 | 2019-2021 | |
| Lundbeck LLC | $30.52 | 2020-2021 | |
| Sobi, INC | $29.76 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $22.85 | 2020 | |
| Emd Serono, INC. | $21.72 | 2022 | |
| Collegium Pharmaceutical, INC. | $19.99 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2020 | |
| Greenwich Biosciences, INC. | $19.37 | 2021 | |
| Harmony Biosciences LLC | $19.01 | 2021 | |
| Merck Sharp & Dohme LLC | $18.48 | 2024 | Vaqta, Gardasil 9, Vaxelis |
| Adamas Pharmaceuticals, INC. | $16.45 | 2020 | |
| Horizon Therapeutics Plc | $15.76 | 2022 | |
| Allergan, INC. | $15.44 | 2020 | |
| Neurocrine Biosciences, INC. | $15.43 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $15.14 | 2020 | |
| Amgen INC. | $12.74 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $12.30 | 2021 | |
| Aquestive Therapeutics, INC. | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bunker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.